1-Azak functions as an anti-tumor agent in PCa cells by downregulating CDK13 and E2F5 expression and thus blocking the CDK13-circCDK13-miR-212/miR-449a-E2F5 regulatory axis. Here, E2F5 is linked to neoplasm.